Health
OHDSI awarded $10 MM FDA contract to monitor safety/effectiveness of vaccines, biologics – EurekAlert
A team of observational health data researchers, coordinated by Columbia University, will support an FDA program to conduct safety and effectiveness surveillance…
NEW YORK, NY (Dec. 1, 2020)–Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.
The lead research team, primarily comprised of OHDSI personnel from Columbia University, UCLA, and Northeastern University,…
-
Noosa News17 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business20 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business17 hours agoDicker Data rides the AI trend to double digit growth
-
Business20 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy